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Ever since the first Surgeon General’s report on smoking in
1964, Americans have learned about the dangerous effects of
smoking and how tragically this habit can end life. It is an
irrefutable fact that smoking cigarettes and using other to-
bacco products causes cancer and often results in other debili-
tating illnesses and death. Our Nation, rightfully, remains on
an important quest to raise public awareness of the dangers of
smoking and to deter people from choosing this costly habit,
particularly our young people.
Too often and for too long, however, smoking has been
largely viewed in the context of men’s health. But smoking
wreaks a great and unique toll on the health of our women
and teenage girls as well. The impact smoking is having on
our Nation’s women is alarming. Therefore, the work of Sur-
geon General David Satcher and the Centers for Disease Con-
trol and Prevention (CDC) in producing this report of the
Surgeon General on women and smoking could not come at a
better time. Frankly, this update and expansion of the 1980
Surgeon General’s report, The Health Consequences of Smoking
for Women, is long due. And we are all grateful for the time
and hard work put into this report by the Surgeon General,
his office, the Office of Women’s Health, the CDC, the Na-
tional Institutes of Health, and researchers and scientists from
around the world.
This report shines a bright light on the devastating impact
of smoking on women and the need for the Nation to come
together and address this problem. Just look at a sample of the
statistics summarized in this report.
• An estimated 27,000 more women died of lung cancer
than of breast cancer in 2000.
• Three million women have died prematurely because of
smoking since 1980, and on average, these women died
14 years prematurely.
• Twenty-two percent of women smoked cigarettes in 1998.
• And 30 percent of high school senior girls reported smok-
ing in the past month, according to recent information.
The report goes well beyond just the statistical impacts of
smoking to lay out specific health problems incurred by women
who smoke. This report found that women who smoke have a
lower bone density and experience a premature decline of lung
function. These women also are at increased risk of concep-
tion delay and both primary and secondary infertility. For
pregnant women who smoke, the risk is increased for low birth
weight, perinatal mortality—both stillbirth and neonatal
deaths—and sudden infant death syndrome after the child is
born. Of course, there are the health dangers of smoking that
most of us are familiar with but remain just as real and just as
deadly for women: cancer, emphysema, heart disease, and
stroke. Now, studies suggest that even exposure to environ-
mental tobacco smoke has a causal link to cancer and heart
disease.
If we are going to succeed in reducing the number of women
who smoke in this country, we must first succeed in prevent-
ing our teenagers and young women from picking up the habit.
Our antismoking efforts at the U.S. Department of Health
and Human Services will focus intensively on keeping tobacco
out of the hands of teenage girls and college-age women. These
young women are greatly influenced by their peers and the
glamor of smoking portrayed through magazines, television,
and movies; we must be aggressive in educating them that
smoking is very addictive, harmful, and lethal. These young
women must know that once they start, it will be difficult to
stop—and that the health risks are very real and costly.
All of society must engage in this endeavor, as well as the
overall challenge of reducing smoking in this Nation, if we
are to succeed. We must re-energize our efforts and commit
time and resources—private and public—to the prevention
of smoking initiation. We need to provide parents, teachers,
and community leaders with tools and information that ef-
fectively convey the destructive message of cigarette use. And
we need all aspects of the media to join the effort in address-
ing this societal problem. Our best defense against the dan-
gers of smoking is a comprehensive approach to tobacco use
prevention, which includes education that is accessible to all.
We must also strengthen the enforcement activities aimed
at preventing youth smoking, including no marketing geared
toward teenagers and absolutely no tobacco sales to minors.
We must fully support law enforcement sting operations and
other improved methods of ensuring that persons who pur-
chase tobacco products are adults.
The cost of smoking is simply too high in this country. The
impacts are a financial drain on our Nation’s health care sys-
tem, costing up to $73 billion annually. But more important,
we are losing too many of our mothers and daughters prema-
turely as a result of smoking. We simply can’t afford to lose
any women to this harmful habit.
This Surgeon General’s report provides an opportunity for
America to focus on how damaging smoking is to the well-
being of our women and girls. We must seize this opportunity
to prevent smoking by women, and help those who do smoke
to quit, which will improve the overall health of women in
this country. And we must do this by working together as a
Nation, for that is the only way we can truly succeed in ad-
dressing this devastating problem.
Message from Tommy G. Thompson
Secretary of Health and Human Services
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Women and girls in the United States are in the throes of an
epidemic of tobacco-related diseases. Over time, the once-wide
gender gap in smoking—and its health consequences—has
narrowed considerably. Cigarette smoking was rare among
women in the early part of this century, increased until the
1960s, and finally began to decline in the mid-1970s. During
the past decade, however, reductions in smoking prevalence
among adult women were minor, and tobacco use among teens
increased markedly. By the late 1990s, more than one in five
adult women was a regular smoker, and about 30 percent of
high school senior girls reported having smoked within the
past 30 days. Many of the tobacco-related diseases that have
manifested today are the result of the cumulative effects of
smoking initiated several decades ago. Unless we succeed in
further curbing tobacco use among women and girls, the health
effects of tobacco use will remain great for the foreseeable fu-
ture.
This report reviews in detail what we know about smoking-
related diseases among women, and documents that the toll
of smoking on women’s health is wide-ranging and stagger-
ing. Like their male counterparts who smoke, women smok-
ers are at increased risk of cancer, cardiovascular disease, and
pulmonary disease, but women also experience unique risks
related to menstrual and reproductive function. In the face of
so many strides that were made during the twentieth century
to improve health outcomes for women, including enormous
declines in maternal mortality, heart disease, and cervical can-
cer, to name but a few, it is tragic that an entirely preventable
factor continues to claim so many women’s lives.
Through its detailed examination of smoking patterns by
demographic and other characteristics, this report confirms
that it is often women who are more socioeconomically dis-
advantaged and girls who perform less well academically who
are most likely to smoke in our society today. For example,
the smoking prevalence in 1998 among women with 9 to 11
years of education was almost three times higher than that
among women who had 16 or more years of education. Once
a mark of sophistication among women in the social fore-
front, then adopted by middle-class women, smoking has in-
creasingly become an addiction borne by women with the least
resources in our society. The long history of tobacco market-
ing targeted to women is also chronicled here. The positive
imagery in cigarette advertisements is greatly at odds with the
negative health consequences suffered by so many women who
smoke.
The importance of vigilance in our efforts to prevent initia-
tion of smoking by girl and to promote cessation among fe-
male smokers of all ages is underscored by this report. To be
successful, we know that a multipronged approach is neces-
sary, including anti-tobacco media campaigns, increases in
tobacco prices, promotion of nonsmoking in public places,
curbs on tobacco advertising and promotion, enforcement of
legislation to reduce youth’s access to tobacco products, and
effective tobacco use treatment programs. Women who smoke
represent diverse subgroups of the population with unique
issues and needs. An important subgroup is pregnant women,
among whom smoking has declined in recent years but re-
mains significant. Efforts to assist quitting among pregnant
women (and their partners) can greatly impact not only their
health but that of their infants and children. We must dra-
matically accelerate declines in smoking among both women
and girls. Exciting models of new tobacco control programs
in states show that this can be done. In Florida, where the
Tobacco Pilot Program was begun in 1998, the prevalence of
current smoking among middle school girls declined from 18.1
percent in 1998 to 10.9 percent in 2000—a 40-percent de-
cline in just two years.
The challenge facing this Nation now is to establish effec-
tive tobacco control programs in every state and nationwide.
No one who reads this report can help but recognize that com-
bating smoking and the forces that promote it deserves to be
among our very highest priorities for women’s health.
Jeffrey P. Koplan, M.D., M.P.H.
Director
Centers for Disease Control and Prevention
and
Administrator
Agency for Toxic Substances and Disease Registry
(1998–2002)
Foreword
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Two decades have passed since the first Surgeon General’s
report on women and smoking was published in 1980. That
report pointed out the first signs of an epidemic of smoking-
related disease among women. This report documents that
the epidemic became full-blown.
Cigarette smoking is the leading cause of preventable death
in the United States, and women’s share of tobacco-related
disease has risen dramatically over the past half century. The
point is underscored by the 600-percent increase since 1950
in women’s death rates for lung cancer, a disease that is primarily
attributable to smoking. Lung cancer accounted for only 3
percent of all female cancer deaths in 1950, whereas in 2000
it accounted for an estimated 25 percent. Already in 1987,
lung cancer had surpassed breast cancer as the leading cause
of cancer death in U.S. women, and in 2000 nearly 27,000
more women died of lung cancer (67,600) than breast cancer
(40,800). In fact, more women are estimated to have died of
lung cancer in the year 2000 than of cancers of the breast,
uterus, and ovary combined. Of course, lung cancer is but
one of the many diseases for which risk is greater among
smokers than nonsmokers.
Despite these facts, 22.0 percent of U.S. adult women
smoked in 1998. Moreover, between 1992 and 1997, the per-
centage of high school senior girls who reported smoking
within the past 30 days increased from 26.1 percent to 35.2
percent before declining to 29.7 percent in 2000.
Since the first Surgeon General’s report on women and smok-
ing in 1980, thousands of studies have expanded both our
knowledge of the effects of smoking on women’s health and
our understanding of the myriad factors that influence smok-
ing initiation, maintenance, and cessation. The need for an
updated compendium on women and smoking is great, and
this report addresses that need.
Ironically, in the face of the overwhelmingly negative health
effects of smoking, tobacco marketing has always used posi-
tive imagery and has attempted to capitalize on issues impor-
tant to women and to exploit the women’s movement. The
same tobacco brand that for so long featured the slogan “You’ve
come a long way, baby” more recently launched an advertis-
ing campaign with the theme “Find your voice.” Tobacco ad-
vertisements suggest that women who smoke are liberated,
sexually attractive, athletic, fun loving, and slim, whereas in
reality women who smoke are often nicotine dependent,
physically unhealthy, socioeconomically disadvantaged, or de-
pressed. Tobacco companies also have tried to ingratiate them-
selves with women’s causes, providing funding for women’s
sports, for women’s professional organizations, and for anti-
domestic violence programs and other issues of salience to
women, not to mention providing huge sums in advertising
revenues to women’s magazines. Perhaps such support has
contributed to the fact that women’s lung cancer does not have
a voice, in contrast to breast cancer, which has such a well-
developed and effective advocacy community.
Although the Healthy People 2000 objective of reducing the
prevalence of current smoking among U.S. adult men and
women to 15 percent is unlikely to be met, we should empha-
size that nearly 80 percent of adult women in this country
choose not to smoke. Nonsmoking is now by far the accepted
norm. If the recommendations in this and previous reports
were fully implemented, the Healthy People 2010 objective to
reduce the rate of tobacco use among girls and women in the
country by more than 50 percent could be met. Hopeful signs
now exist that the lung cancer epidemic may have peaked
among U.S. women. As this report goes to press, encouraging
news comes from a report issued by the Centers for Disease
Control and Prevention based on data from California and
from the National Cancer Institute. In California, which has
been at the forefront of tobacco control activities and where
smoking prevalence has declined more rapidly than in the rest
of the country, the lung cancer incidence rate among women
has actually declined in recent years. Another report from
California found that 33,300 fewer heart disease deaths oc-
curred in the state between 1989 and 1997 among women
and men combined than would have been expected during
that time had earlier trends in heart disease mortality relative
to the rest of the United States continued. California was the
first state to implement a comprehensive statewide tobacco
control program funded by a cigarette surtax that began in
1989. Today all states have enormous monetary settlement
payments from the state lawsuits with the tobacco industry to
recover the cost of smoking-related disease; unfortunately, few
states have used these new resources to make the level of in-
vestments in the proven tobacco control strategies that could
reduce the disease and death rates related to smoking.
Women in the United States and a number of other devel-
oped countries are less likely to be smokers than was the case
Preface
from the Surgeon General,
U.S. Department of Health and Human Services
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30 years ago. However, just the opposite trend is feared for
women in many other parts of the world, particularly women
in developing countries where smoking prevalence has tradi-
tionally been low but where the tobacco industry now recog-
nizes tremendous market potential and is aggressively pursu-
ing females. Thwarting increases in the use of tobacco among
women around the world represents one of the greatest public
health opportunities of our time.
David Satcher, M.D., Ph.D.
Surgeon General (1997–2002)
Vol. 51 / RR-12 Recommendations and Reports 1
This is the second report of the U.S. Surgeon General
devoted to women and smoking. The first was published in
1980 (U.S. Department of Health and Human Services
[USDHHS] 1980), 16 years after the initial landmark report
on smoking and health of the Advisory Committee to the
Surgeon General appeared in 1964 (U.S. Department of
Health, Education, and Welfare [USDHEW] 1964). The 1964
report summarized the accumulated evidence that demon-
strated that smoking was a cause of human cancer and other
diseases. Most of the early evidence was based on men. For
example, the report concluded, “Cigarette smoking is causally
related to lung cancer in men.... The data for women, though
less extensive, point in the same direction” (USDHEW 1964,
p. 37). By the time of the 1980 report, the evidence clearly
showed that women were also experiencing devastating health
consequences from smoking and that “the first signs of an
epidemic of smoking-related disease among women are now
appearing” (USDHHS 1980, p. v). The evidence had solidi-
fied later among women than among men because smoking
became commonplace among women about 25 years later than
it had among men. However, it was still deemed necessary to
include a section in the preface of the 1980 report titled “The
Fallacy of Women’s Immunity.” In the two decades since,
numerous studies have expanded the breadth and depth of
what is known about the health consequences of smoking
among women, about historical and contemporary patterns
of smoking in demographic subgroups of the female popula-
tion, about factors that affect initiation and maintenance of
smoking among women (including advertising and market-
ing of tobacco products), and about interventions to assist
women to quit smoking. The present report reviews the now
massive body of evidence on women and smoking—evidence
that taken together compels the Nation to make reducing and
preventing smoking one of the highest contemporary priori-
ties for women’s health.
A report focused on women is greatly needed. No longer are
the first signs of an epidemic of tobacco-related diseases among
women being seen, as was the case when the 1980 report was
written. Since 1980, hundreds of additional studies have ex-
panded what is known about the health effects of smoking
among women, and this report summarizes that knowledge.
Today the Nation is in the midst of a full-blown epidemic.
Lung cancer, once rare among women, has surpassed breast
cancer as the leading cause of female cancer death in the United
States, now accounting for 25 percent of all cancer deaths
among women. Surveys have indicated that many women do
not know this fact. And lung cancer is only one of myriad
serious disease risks faced by women who smoke. Although
women and men who smoke share excess risks for diseases
such as cancer, heart disease, and emphysema, women also
experience unique smoking-related disease risks related to preg-
nancy, oral contraceptive use, menstrual function, and cervi-
cal cancer. These risks deserve to be highlighted and broadly
recognized. Moreover, much of what is known about the health
effects of exposure to environmental tobacco smoke among
nonsmokers comes from studies of women, because historically
men were more likely than women to smoke and because many
women who did not smoke were married to smokers.
In 1965, 51.9 percent of men were smokers, whereas 33.9
percent of women were smokers. By 1979, the percentage of
women who smoked had declined somewhat, to 29.9 per-
cent. However, the decline in smoking among men to 37.5
percent was much more dramatic. The gender gap in adult
smoking prevalence continued to close after the 1980 report,
but since the mid-1980s, the difference has been fairly stable
at about 5 percentage points. In 1998, smoking prevalence
was 22.0 percent among women and 26.4 percent among men.
The gender difference in smoking prevalence among teens is
smaller than that among adults. Smoking prevalence increased
among both girls and boys in the 1990s. In 2000, 29.7 per-
cent of high school senior girls and 32.8 percent of high school
senior boys reported having smoked within the past 30 days
(University of Michigan 2000).
In recent years, some research has suggested that the impact
of a given amount of smoking on lung cancer risk might be
even greater among women than among men, that exposure
to environmental tobacco smoke might be associated with
increased risk for breast cancer, and that women might be
more susceptible than men to weight gain following smoking
cessation. Other research indicated that persons with specific
genetic polymorphisms may be especially susceptible to the
effects of smoking and exposure to environmental tobacco
smoke. These issues remain active areas of investigation, and
no conclusions can be drawn about them at this time. None-
theless, knowledge of the vast spectrum of smoking-related
health effects continues to grow, as does knowledge that
examination of gender-specific effects is important.
Smoking is one of the most studied of human behaviors
and thousands of studies have documented its health conse-
quences, yet certain questions and data needs exist with
respect to women and smoking. For example, there is a need
to better understand why smoking prevalence increased among
Women and Smoking: A Report of the Surgeon General
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teenage girls and young women in the 1990s despite the over-
whelming data on adverse health effects; to identify interven-
tions and policies that will prevent an epidemic of tobacco use
among women whose smoking prevalence is currently low,
including women in certain sociocultural groups within the
United States and women in many developing countries
throughout the world; to study the relationship of active smok-
ing to diseases among women for which the evidence to date
has been suggestive or inconsistent (e.g., risks for menstrual
cycle irregularities, gallbladder disease, and systemic lupus
erythematosus); to increase the data on the health effects of
exposure to environmental tobacco smoke on diseases unique
among women; to provide additional research on whether
gender differences exist in susceptibility to nicotine addiction
or in the magnitude of the effects of smoking on specific dis-
ease outcomes; and to determine whether gender differences
exist in the modifying effects of genetic polymorphisms on
disease risks associated with smoking. Many studies of smok-
ing behavior and of the health consequences of smoking have
included both females and males but have not reported results
by gender. Investigators should be encouraged to report gender-
specific results in the future.
Other recent reports of the Surgeon General have been
devoted to smoking and youth (USDHHS 1994), smoking
and racial or ethnic minorities (USDHHS 1998), and inter-
ventions to reduce smoking (USDHHS 2000). The reader is
encouraged to consult those reports for comprehensive reviews
of the evidence on these topics. The present report focuses on
data specific to women and girls and on comparisons of
results by gender.
Chapter 1. Major Conclusions
1. Despite all that is known of the devastating health
consequences of smoking, 22.0 percent of women
smoked cigarettes in 1998. Cigarette smoking became
prevalent among men before women, and smoking
prevalence in the United States has always been lower
among women than among men. However, the once-
wide gender gap in smoking prevalence narrowed until
the mid-1980s and has since remained fairly constant.
Smoking prevalence today is nearly three times higher
among women who have only 9 to 11 years of education
(32.9 percent) than among women with 16 or more years
of education (11.2 percent).
2. In 2000, 29.7 percent of high school senior girls reported
having smoked within the past 30 days. Smoking
prevalence among white girls declined from the mid-
1970s to the early 1980s, followed by a decade of little
change. Smoking prevalence then increased markedly in
the early 1990s, and declined somewhat in the late 1990s.
The increase dampened much of the earlier progress.
Among black girls, smoking prevalence declined
substantially from the mid-1970s to the early 1990s,
followed by some increases until the mid-1990s. Data
on long-term trends in smoking prevalence among high
school seniors of other racial or ethnic groups are not
available.
3. Since 1980, approximately 3 million U.S. women have
died prematurely from smoking-related neoplastic,
cardiovascular, respiratory, and pediatric diseases, as well
as cigarette-caused burns. Each year during the 1990s,
U.S. women lost an estimated 2.1 million years of life
due to these smoking attributable premature deaths.
Additionally, women who smoke experience gender-
specific health consequences, including increased risk
of various adverse reproductive outcomes.
4. Lung cancer is now the leading cause of cancer death
among U.S. women; it surpassed breast cancer in 1987.
About 90 percent of all lung cancer deaths among women
who continue to smoke are attributable to smoking.
5. Exposure to environmental tobacco smoke is a cause of
lung cancer and coronary heart disease among women
who are lifetime nonsmokers. Infants born to women
exposed to environmental tobacco smoke during
pregnancy have a small decrement in birth weight and a
slightly increased risk of intrauterine growth retardation
compared to infants of nonexposed women.
6. Women who stop smoking greatly reduce their risk of
dying prematurely, and quitting smoking is beneficial
at all ages. Although some clinical intervention studies
suggest that women may have more difficulty quitting
smoking than men, national survey data show that
women are quitting at rates similar to or even higher
than those for men. Prevention and cessation
interventions are generally of similar effectiveness for
women and men and, to date, few gender differences in
factors related to smoking initiation and successful
quitting have been identified.
7. Smoking during pregnancy remains a major public
health problem despite increased knowledge of the
adverse health effects of smoking during pregnancy.
Although the prevalence of smoking during pregnancy
has declined steadily in recent years, substantial numbers
of pregnant women continue to smoke, and only about
one-third of women who stop smoking during pregnancy
are still abstinent one year after the delivery.
8. Tobacco industry marketing is a factor influencing
susceptibility to and initiation of smoking among girls,
in the United States and overseas. Myriad examples of
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tobacco ads and promotions targeted to women indicate
that such marketing is dominated by themes of social
desirability and independence. These themes are conveyed
through ads featuring slim, attractive, athletic models,
images very much at odds with the serious health
consequences experienced by so many women who smoke.
Chapter Conclusions
Conclusions from Chapters 2–5 are presented below. Sepa-
rate conclusions are not included for Chapter 1 because it is a
summary of the report. Chapter 6, which presents a vision for
the future, is reproduced in its entirety following the conclu-
sions for Chapters 2–5.
Chapter 2. Patterns of Tobacco
 Use Among Women and Girls
1. Cigarette smoking became prevalent among women after
it did among men, and smoking prevalence has always
been lower among women than among men. The gender-
specific difference in smoking prevalence narrowed
between 1965 and 1985. Since 1985, the decline in
prevalence has been comparable among women and men.
2. The prevalence of current smoking among women
increased from less than 6 percent in 1924 to 34 percent
in 1965, then declined to 22 to 23 percent in the late
1990s. In 1997–1998, smoking prevalence was highest
among American Indian or Alaska Native women (34.5
percent), intermediate among white women (23.5
percent) and black women (21.9 percent), and lowest
among Hispanic women (13.8 percent) and Asian or
Pacific Islander women (11.2 percent). By educational
level, smoking prevalence is nearly three times higher
among women with 9 to 11 years of education (30.9
percent) than among women with 16 or more years of
education (10.6 percent).
3. Much of the progress in reducing smoking prevalence
among girls in the 1970s and 1980s was lost with the
increase in prevalence in the 1990s: current smoking
among high school senior girls was the same in 2000 as
in 1998. Although smoking prevalence was higher
among high school senior girls than among high school
senior boys in the 1970s and early 1980s, prevalence has
been comparable since the mid-1980s.
4. Smoking declined substantially among black girls from
the mid-1970s through the early 1990s; the decline
among white girls for this same period was small. As
adolescents age into young adulthood, these patterns are
now being reflected in the racial and ethnic differences
in smoking among young women. Data are not available
on long-term trends in smoking prevalence among high
school seniors of other racial and ethnic groups.
5. Smoking during pregnancy appears to have decreased from
1989 through 1998. Despite increased knowledge of the
adverse health effects of smoking during pregnancy,
estimates of women smoking during pregnancy range from
12 percent based on birth certificate data to as high as
22 percent based on survey data.
6. Historically, women started to smoke at a later age than
did men, but beginning with the 1960 cohort, the mean
age at smoking initiation has not differed by gender.
7. Nicotine dependence is strongly associated with the
number of cigarettes smoked per day. Girls and women
who smoke appear to be equally dependent on nicotine
when results are stratified by number of cigarettes smoked
per day. Few gender-specific differences have been found
in indicators of nicotine dependence among adolescents,
young adults, or adults overall.
8. The percentage of persons who have ever smoked and
who have quit smoking is somewhat lower among
women (46.2 percent) than among men (50.1 percent).
This finding is probably because men began to stop
smoking earlier in the twentieth century than did women
and because these data do not take into account that
men are more likely than women to switch to or to
continue to use other tobacco products when they stop
smoking cigarettes. Since the late 1970s or early 1980s,
the probability of attempting to quit smoking and to
succeed has been equally high among women and men.
9. Prevalence of the use of cigars, pipes, and smokeless
tobacco among women is generally low, but recent data
suggest that cigar smoking among women and girls is
increasing.
10. Smoking prevalence among women varies markedly
across countries; the percentages range from an estimated
7 percent in developing countries to 24 percent in
developed countries. Thwarting further increases in
tobacco use among women is one of the greatest disease
prevention opportunities in the world today.
Chapter 3. Health Consequences
of Tobacco Use Among Women
Total Mortality
1. Cigarette smoking plays a major role in the mortality of
U.S. women.
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2. The excess risk for death from all causes among current
smokers compared with persons who have never smoked
increases with both the number of years of smoking and
the number of cigarettes smoked per day.
3. Among women who smoke, the percentage of deaths
attributable to smoking has increased over the past several
decades, largely because of increases in the quantity of
cigarettes smoked and the duration of smoking.
4. Cohort studies with follow-up data analyzed in the 1980s
show that the annual risk for death from all causes is 80
to 90 percent greater among women who smoke cigarettes
than among women who never smoked. A woman’s
annual risk for death more than doubles among continuing
smokers compared with persons who have never smoked
in every age group from 45 through 74 years.
5. In 1997, approximately 165,000 U.S. women died
prematurely from a smoking-related disease. Since 1980,
approximately three million U.S. women have died
prematurely from a smoking-related disease.
6. U.S. females lost an estimated 2.1 million years of life
each year during the 1990s as a result of smoking-related
deaths due to neoplastic, cardiovascular, respiratory, and
pediatric diseases, as well as from burns caused by
cigarettes. For every smoking attributable death, an
average of 14 years of life was lost.
7. Women who stop smoking greatly reduce their risk of
dying prematurely. The relative benefits of smoking
cessation are greater when women stop smoking at younger
ages, but smoking cessation is beneficial at all ages.
Lung Cancer
8. Cigarette smoking is the major cause of lung cancer
among women. About 90 percent of all lung cancer
deaths among U.S. women smokers are attributable to
smoking.
9. The risk for lung cancer increases with quantity, duration,
and intensity of smoking. The risk for dying of lung
cancer is 20 times higher among women who smoke
two or more packs of cigarettes per day than among
women who do not smoke.
10. Lung cancer mortality rates among U.S. women have
increased about 600 percent since 1950. In 1987, lung
cancer surpassed breast cancer to become the leading
cause of cancer death among U.S. women. Overall age-
adjusted incidence rates for lung cancer among women
appear to have peaked in the mid-1990s.
11. In the past, men who smoked appeared to have a higher
relative risk for lung cancer than did women who
smoked, but recent data suggest that such differences
have narrowed considerably. Earlier findings largely
reflect past gender-specific differences in duration and
amount of cigarette smoking.
12. Former smokers have a lower risk for lung cancer than
do current smokers, and risk declines with the number
of years of smoking cessation.
International Trends in Female
Lung Cancer
13. International lung cancer death rates among women vary
dramatically. This variation reflects historical differences
in the adoption of cigarette smoking by women in
different countries. In 1990, lung cancer accounted for
about 10 percent of all cancer deaths among women
worldwide and more than 20 percent of cancer deaths
among women in some developed countries.
Female Cancers
14. The totality of the evidence does not support an
association between smoking and risk for breast cancer.
15. Several studies suggest that exposure to environmental
tobacco smoke is associated with an increased risk for
breast cancer, but this association remains uncertain.
16. Current smoking is associated with a reduced risk for
endometrial cancer, but the effect is probably limited to
postmenopausal disease. The risk for this cancer among
former smokers generally appears more similar to that
of women who have never smoked.
17. Smoking does not appear to be associated with risk of
ovarian cancer.
18. Smoking has been consistently associated with an
increased risk for cervical cancer. The extent to which
this association is independent of human papillomavirus
infection is uncertain.
19. Smoking may be associated with an increased risk for
vulvar cancer, but the extent to which the association is
independent of human papillomavirus infection is
uncertain.
Other Cancers
20. Smoking is a major cause of cancers of the oropharynx
and bladder among women. Evidence is also strong that
women who smoke have increased risks for cancers of
the pancreas and kidney. For cancers of the larynx and
esophagus, evidence among women is more limited but
consistent with large increases in risk.
21. Women who smoke may have increased risks for liver
cancer and colorectal cancer.
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22. Data on smoking and cancer of the stomach among
women are inconsistent.
23. Smoking may be associated with an increased risk for
acute myeloid leukemia among women but does not
appear to be associated with other lymphoproliferative
or hematologic cancers.
24. Women who smoke may have a decreased risk for thyroid
cancer.
25. Women who use smokeless tobacco have an increased
risk for oral cancer.
Cardiovascular Disease
26. Smoking is a major cause of coronary heart disease
among women. For women younger than 50 years, the
majority of coronary heart disease is attributable to
smoking. Risk increases with the number of cigarettes
smoked and the duration of smoking.
27. The risk for coronary heart disease among women is
substantially reduced within 1 or 2 years of smoking
cessation. This immediate benefit is followed by a
continuing but more gradual reduction in risk to that
among non-smokers by 10 to 15 or more years after
cessation.
28. Women who use oral contraceptives have a particularly
elevated risk of coronary heart disease if they smoke.
Currently, evidence is conflicting as to whether the effect
of hormone replacement therapy on coronary heart
disease risk differs between smokers and nonsmokers.
29. Women who smoke have an increased risk for ischemic
stroke and subarachnoid hemorrhage. Evidence is
inconsistent concerning the association between
smoking and primary intracerebral hemorrhage.
30. In most studies that include women, the increased risk
for stroke associated with smoking is reversible after
smoking cessation; after 5 to 15 years of abstinence, the
risk approaches that of women who have never smoked.
31. Conflicting evidence exists regarding the level of the risk
for stroke among women who both smoke and use either
the oral contraceptives commonly prescribed in the
United States today or hormone replacement therapy.
32. Smoking is a strong predictor of the progression and
severity of carotid atherosclerosis among women.
Smoking cessation appears to slow the rate of progression
of carotid atherosclerosis.
33. Women who are current smokers have an increased risk
for peripheral vascular atherosclerosis. Smoking cessation
is associated with improvements in symptoms, prognosis,
and survival.
34. Women who smoke have an increased risk for death from
ruptured abdominal aortic aneurysm.
Chronic Obstructive Pulmonary
Disease (COPD) and Lung Function
35. Cigarette smoking is a primary cause of COPD among
women, and the risk increases with the amount and
duration of smoking. Approximately 90 percent of
mortality from COPD among women in the United
States can be attributed to cigarette smoking.
36. In utero exposure to maternal smoking is associated with
reduced lung function among infants, and exposure to
environmental tobacco smoke during childhood and
adolescence may be associated with impaired lung
function among girls.
37. Adolescent girls who smoke have reduced rates of lung
growth, and adult women who smoke experience a
premature decline of lung function.
38. The rate of decline in lung function is slower among
women who stop smoking than among women who
continue to smoke.
39. Mortality rates for COPD have increased among women
over the past 20 to 30 years.
40. Although data for women are limited, former smokers
appear to have a lower risk for dying from COPD than
do current smokers.
Sex Hormones, Thyroid Disease,
and Diabetes Mellitus
41. Women who smoke have an increased risk for estrogen-
deficiency disorders and a decreased risk for estrogen-
dependent disorders, but circulating levels of the major
endogenous estrogens are not altered among women
smokers.
42. Although consistent effects of smoking on thyroid
hormone levels have not been noted, cigarette smokers
may have an increased risk for Graves’ ophthalmopathy,
a thyroid-related disease.
43. Smoking appears to affect glucose regulation and related
metabolic processes, but conflicting data exist on the
relationship of smoking and the development of type 2
diabetes mellitus and gestational diabetes among women.
Menstrual Function, Menopause,
and Benign Gynecologic Conditions
44. Some studies suggest that cigarette smoking may alter
menstrual function by increasing the risks for
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dysmenorrhea (painful menstruation), secondary
amenorrhea (lack of menses among women who ever
had menstrual periods), and menstrual irregularity.
45. Women smokers have a younger age at natural
menopause than do nonsmokers and may experience
more menopausal symptoms.
46. Women who smoke may have decreased risk for uterine
fibroids.
Reproductive Outcomes
47. Women who smoke have increased risks for conception
delay and for both primary and secondary infertility.
48. Women who smoke may have a modest increase in risks
for ectopic pregnancy and spontaneous abortion.
49. Smoking during pregnancy is associated with increased
risks for preterm premature rupture of membranes,
abruptio placentae, and placenta previa, and with a
modest increase in risk for preterm delivery.
50. Women who smoke during pregnancy have a decreased
risk for preeclampsia.
51. The risk for perinatal mortality—both stillbirth and
neonatal deaths—and the risk for sudden infant death
syndrome (SIDS) are increased among the offspring of
women who smoke during pregnancy.
52. Infants born to women who smoke during pregnancy
have a lower average birth weight and are more likely to
be small for gestational age than are infants born to
women who do not smoke.
53. Smoking does not appear to affect the overall risk for
congenital malformations.
54. Women smokers are less likely to breastfeed their infants
than are women nonsmokers.
55. Women who quit smoking before or during pregnancy
reduce the risk for adverse reproductive outcomes,
including conception delay, infertility, preterm premature
rupture of membranes, preterm delivery, and low birth
weight.
Body Weight and Fat Distribution
56. Initiation of cigarette smoking does not appear to be
associated with weight loss, but smoking does appear to
attenuate weight gain over time.
57. The average weight of women who are current smokers
is modestly lower than that of women who have never
smoked or who are long-term former smokers.
58. Smoking cessation among women typically is associated
with a weight gain of about 6 to 12 pounds in the year
after they quit smoking.
59. Women smokers have a more masculine pattern of body
fat distribution (i.e., a higher waist-to-hip ratio) than
do women who have never smoked.
Bone Density and Fracture Risk
60. Postmenopausal women who currently smoke have lower
bone density than do women who do not smoke.
61. Women who currently smoke have an increased risk for
hip fracture compared with women who do not smoke.
62. The relationship among women between smoking and
the risk for bone fracture at sites other than the hip is
not clear.
Gastrointestinal Diseases
63. Some studies suggest that women who smoke have an
increased risk for gallbladder disease (gallstones and
cholecystitis), but the evidence is inconsistent.
64. Women who smoke have an increased risk for peptic
ulcers.
65. Women who currently smoke have a decreased risk for
ulcerative colitis, but former smokers have an increased
risk—possibly because smoking suppresses symptoms of
the disease.
66. Women who smoke appear to have an increased risk for
Crohn’s disease, and smokers with Crohn’s disease have
a worse prognosis than do nonsmokers.
Arthritis
67. Some but not all studies suggest that women who smoke
may have a modestly elevated risk for rheumatoid
arthritis.
68. Women who smoke have a modestly reduced risk for
osteoarthritis of the knee; data regarding osteoarthritis
of the hip are inconsistent.
69. The data on the risk of systemic lupus erythematosus
among women who smoke are inconsistent.
Eye Disease
70. Women who smoke have an increased risk for cataract.
71. Women who smoke may have an increased risk for age-
related macular degeneration.
72. Studies show no consistent association between smoking
and open-angle glaucoma.
Human Immunodeficiency Virus
(HIV) Disease
73. Limited data suggest that women smokers may be at
higher risk for HIV-1 infection than nonsmokers.
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Facial Wrinkling
74. Limited but consistent data suggest that women smokers
have more facial wrinkling than do nonsmokers.
Depression and Other
Psychiatric Disorders
75. Smokers are more likely to be depressed than are
nonsmokers, a finding that may reflect an effect of
smoking on the risk for depression, the use of smoking
for self-medication, or the influence of common genetic
or other factors on both smoking and depression. The
association of smoking and depression is particularly
important among women because they are more likely
to be diagnosed with depression than are men.
76. The prevalence of smoking generally has been found to
be higher among patients with anxiety disorders, bulimia,
attention deficit disorder, and alcoholism than among
individuals without these conditions; the mechanisms
underlying these associations are not yet understood.
77. The prevalence of smoking is very high among patients
with schizophrenia, but the mechanisms underlying this
association are not yet understood.
78. Smoking may be used by some persons who would
otherwise manifest psychiatric symptoms to manage
those symptoms; for such persons, cessation of smoking
may lead to the emergence of depression or other
dysphoric mood states.
Neurologic Diseases
79. Women who smoke have a decreased risk for Parkinson’s
disease.
80. Data regarding the association between smoking and
Alzheimer’s disease are inconsistent.
Nicotine Pharmacology and Addiction
81. Nicotine pharmacology and the behavioral processes that
determine nicotine addiction appear generally similar
among women and men; when standardized for the
number of cigarettes smoked, the blood concentration
of cotinine (the main metabolite of nicotine) is similar
among women and men.
82. Women’s regulation of nicotine intake may be less precise
than men’s. Factors other than nicotine (e.g., sensory
cues) may play a greater role in determining smoking
behavior among women.
Environmental Tobacco Smoke (ETS)
and Lung Cancer
83. Exposure to ETS is a cause of lung cancer among women
who have never smoked.
ETS and Coronary Heart Disease
84. Epidemiologic and other data support a causal
relationship between ETS exposure from the spouse and
coronary heart disease mortality among women
nonsmokers.
ETS and Reproductive Outcomes
85. Infants born to women who are exposed to ETS during
pregnancy may have a small decrement in birth weight
and a slightly increased risk for intrauterine growth
retardation compared with infants born to women who
are not exposed; both effects are quite variable across
studies.
86. Studies of ETS exposure and the risks for delay in
conception, spontaneous abortion, and perinatal
mortality are few, and the results are inconsistent.
Chapter 4. Factors Influencing
Tobacco Use Among Women
1. Girls who initiate smoking are more likely than those
who do not smoke to have parents or friends who smoke.
They also tend to have weaker attachments to parents
and family and stronger attachments to peers and friends.
They perceive smoking prevalence to be higher than it
actually is, are inclined to risk taking and rebelliousness,
have a weaker commitment to school or religion, have
less knowledge of the adverse consequences of smoking
and the addictiveness of nicotine, believe that smoking
can control weight and negative moods, and have a
positive image of smokers. Although the strength of the
association by gender differs across studies, most of these
factors are associated with an increased risk for smoking
among both girls and boys.
2. Girls appear to be more affected than boys by the desire
to smoke for weight control and by the perception that
smoking controls negative moods; girls may also be more
influenced than boys to smoke by rebelliousness or a
rejection of conventional values.
3. Women who continue to smoke and those who fail at
attempts to stop smoking tend to have lower education
and employment levels than do women who quit
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smoking. They also tend to be more addicted to
cigarettes, as evidenced by the smoking of a higher
number of cigarettes per day, to be cognitively less ready
to stop smoking, to have less social support for stopping,
and to be less confident in resisting temptations to smoke.
4. Women have been extensively targeted in tobacco
marketing, and tobacco companies have produced brands
specifically for women, both in the United States and
overseas. Myriad examples of tobacco ads and
promotions targeted to women indicate that such
marketing is dominated by themes of both social
desirability and independence, which are conveyed
through ads featuring slim, attractive, athletic models.
Between 1995 and 1998, expenditures for domestic
cigarette advertising and promotion increased
37.3 percent, from $4.90 billion to $6.73 billion.
5. Tobacco industry marketing, including product design,
advertising, and promotional activities, is a factor
influencing susceptibility to and initiation of smoking.
6. The dependence of the media on revenues from tobacco
advertising oriented to women, coupled with tobacco
company sponsorship of women’s fashions and of
artistic, athletic, political, and other events, has tended
to stifle media coverage of the health consequences of
smoking among women and to mute criticism of the
tobacco industry by women public figures.
Chapter 5. Efforts to Reduce Tobacco
Use Among Women
1. Using evidence from studies that vary in design, sample
characteristics, and intensity of the interventions studied,
researchers to date have not found consistent gender-
specific differences in the effectiveness of intervention
programs for tobacco use. Some clinical studies have
shown lower cessation rates among women than among
men, but others have not. Many studies have not reported
cessation results by gender.
2. Among women, biopsychosocial factors, such as
pregnancy, fear of weight gain, depression, and the need
for social support, appear to be associated with smoking
maintenance, cessation, or relapse.
3. A higher percentage of women stop smoking during
pregnancy, both spontaneously and with assistance, than
at other times in their lives. Using pregnancy-specific
programs can increase smoking cessation rates, which
benefits infant health and is cost effective. Only about
one-third of women who stop smoking during pregnancy
are still abstinent one year after the delivery.
4. Women fear weight gain during smoking cessation more
than do men. However, few studies have found a
relationship between weight concerns and smoking
cessation for either women or men. Further, actual weight
gain during cessation does not predict relapse to smoking.
5. Adolescent girls are more likely than adolescent boys to
respond to smoking cessation programs that include
social support from the family or their peer group.
6. Among persons who smoke heavily, women are more
likely than men to report being dependent on cigarettes
and to have lower expectations about stopping smoking,
but it is not clear if such women are less likely to quit
smoking.
7. Currently, no tobacco cessation method has proved to
be any more or less successful among minority women
than among white women in the same study, but research
on smoking cessation among women of most racial and
ethnic minorities has been scarce.
8. Women are more likely than men to affirm that they
smoke less at work because of a worksite policy and are
significantly more likely than men to attribute reduced
amount of daily smoking to their worksite policy.
Women also are more likely than men to support policies
designed to prevent smoking initiation among
adolescents, restrictions on youth access to tobacco
products, and limits on tobacco advertising and
promotion.
9. Successful interventions have been developed to prevent
smoking among young people, but little systematic effort
has been focused on developing and evaluating
prevention interventions specifically for girls.
A Vision for the Future:
What Is Needed to Reduce Smoking
Among Women
This report summarizes what is known about smoking
among women, including patterns and trends in smoking
prevalence, factors associated with smoking initiation and
maintenance, the consequences of smoking for women’s health,
and interventions for smoking cessation and prevention. The
report also describes historical and contemporary tobacco
marketing targeted to women. Evidence of the health conse-
quences of smoking, which had emerged somewhat earlier
among men because of their earlier uptake of smoking, is now
overwhelming among women. Tragically, in the face of con-
tinually mounting evidence of the enormous consequences of
smoking for women’s health, the tobacco industry continues
to heavily target women in its advertising and promotional
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campaigns and is now attempting to export the epidemic of
smoking to women in areas of the world where the smoking
prevalence among females has traditionally been low. The single
overarching theme emerging from this report is that smoking
is a women’s issue. What is needed to curb the epidemic of
smoking and smoking-related diseases among women in the
United States and throughout the world?
Increase Awareness of the Impact
of Smoking on Women’s Health
and Counter the Tobacco Industry’s
Targeting of Women
• Increase awareness of the devastating impact of smok-
ing on women’s health. Since 1980, when the first Sur-
geon General’s report on women and smoking was
published documenting the serious health consequences
of smoking among women, the number of women
affected by smoking-related diseases has increased dramati-
cally. Smoking is now the leading known cause of pre-
ventable death and disease among women. Each year
during the 1990s it accounted for more than 140,000
deaths among U.S. women. By 1987, lung cancer became
the leading cause of cancer death among women, and in
2000 approximately 27,000 more women in the United
States died of lung cancer (67,600) than of breast cancer
(40,800). Smoking also claims women’s lives through
deaths due to other types of cancer as well as to cardiovas-
cular, pulmonary, and other diseases—all risks shared with
men who smoke. In addition, women experience unique
health effects due to smoking, such as those related to
pregnancy. In 1997, smoking accounted for an estimated
165,000 premature deaths among U.S. women. Exposure
to environmental tobacco smoke also contributes to lung
cancer and heart disease deaths among women and
affects the health of their infants. The media, including
women’s magazines and broadcast programming, can play
an important role in raising women’s awareness of the
magnitude of the impact of smoking on their health and
in prioritizing the importance of smoking relative to the
myriad other health-related topics covered.
• Expose and counter the tobacco industry’s deliberate
targeting of women and decry its efforts to link smok-
ing, which is so harmful to women’s health, with
women’s rights and progress in society. Even in the face
of amassing evidence that a large percentage of women
who smoke will die early, the tobacco industry has
exploited themes of liberation and success in its
advertising—particularly in women’s magazines—and
promotions targeted to women. Through its sponsorship
of women’s sports, women’s professional and leadership
organizations, the arts, and so on, the industry has
attempted to associate itself with things women most value
(e.g., recent heavily advertised support from a major
 tobacco company for programs to curb domestic violence
against women) (Levin 1999; Bischoff 2000–01). Such
associations should be decried for what they are: attempts
by the tobacco industry to position itself as an ally of
women’s causes and thereby to silence potential critics.
Women should be appropriately concerned by and speak
out against tobacco marketing campaigns that co-opt the
language of women’s empowerment, and they should rec-
ognize the irony of attempts by the tobacco industry to
suggest that smoking—which leads to nicotine depen-
dence and death among many women—is a form of
independence. Such efforts on the part of women would
be unnecessary if the tobacco industry would voluntarily
refrain from targeting women and associating tobacco use
with women’s freedom and progress.
Support Women’s Anti-Tobacco
Advocacy Efforts and Publicize
that Most Women Are Nonsmokers
• Encourage a more vocal constituency on issues related
to women and smoking. Taking a lesson from the suc-
cess of advocacy to reduce breast cancer, concerted efforts
are needed to call public attention to the toll that lung
cancer and other smoking-related diseases is exacting on
women’s health and to demand accountability on the part
of the tobacco industry. Women affected by tobacco-
related diseases and their families and friends can partner
with women’s and girls’ organizations, women’s maga-
zines, female celebrities, and others—not only in an
effort to raise awareness of tobacco-related disease as a
women’s issue, but also to call for policies and programs
that deglamorize and discourage tobacco use. Some
excellent but relatively small-scale efforts have already
taken place in this area, but because of the magnitude of
the problem, these efforts deserve much greater support.
• Recognize that nonsmoking is by far the norm among
women. Although in recent years smoking prevalence has
not declined as much as might be hoped, nearly four-
fifths of U.S. women are nonsmokers. In some subgroups
of the population, smoking is relatively rare (e.g., only
11.2 percent of adult women who have completed col-
lege are current smokers, and only 5.4 percent of black
high school senior girls are daily smokers). Despite the
positive images of women in tobacco advertisements, it is
important to recognize that among adult women, those
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who are the most empowered, as measured by educational
attainment, are the least likely to be smokers. Moreover,
most women who do smoke say they would like to quit.
The fact that almost all women have either rejected smok-
ing for themselves or, if they do smoke now, wish to quit,
should be promoted.
Continue to Build the Science Base
on Gender-Specific Outcomes
and on How to Reduce Disparities
Among Women
• Conduct further studies of the relationship between
smoking and certain outcomes of importance to
women’s health. For example, does exposure to environ-
mental tobacco smoke increase the risk for breast cancer?
Some case-control studies suggested that possibility, but
the link remains controversial, especially because relatively
little evidence exists thus far supporting an association
between active smoking and breast cancer. Any health
effects of exposure to environmental tobacco smoke may
be particularly important among women in developing
countries, where the vast majority of women are non-
smokers but smoking prevalence among men is high.
Tobacco products, particularly the cigarette brands that
have been most heavily promoted to women smokers, may
vary significantly in the levels of known carcinogens; how-
ever, little data exist on how much brands vary in toxicity
and whether any of these possible variations may be
related to the changes in lung cancer histology over the
last decades. More research is needed to evaluate whether
changes in the tobacco product and increased exposure to
tobacco-specific nitrosamines may be related to the
increased incidence rates of adenocarcinoma of the lung.
More data are also needed on the effects of employment
in tobacco production on women’s health, including data
on reproductive outcomes among women who work with
tobacco during pregnancy. This topic is not covered in
the present report because of a paucity of information. In
general, much better data are needed on the health effects
of smoking among women in the developing world. Are
the effects similar to those reported in the literature to
date, which is based largely on studies of women smokers
in the developed world, or are they modified by differ-
ences in lifestyle and environmental factors such as diet,
viral exposures, or other sources of indoor air pollution?
• Encourage the reporting of gender-specific results
from studies of factors influencing smoking behavior,
smoking prevention and cessation interventions, and
the health effects of tobacco use, including use of new
tobacco products. The evidence to date has suggested
that more similarities than differences exist between
women and men in the factors that influence smoking
initiation, addiction, and smoking cessation. When dif-
ferences in smoking history are taken into account, health
consequences also are generally similar. These conclusions
are tempered by the fact that many research studies are
not reporting gender-specific results. However, some stud-
ies do report gender differences in smoking cessation and
the health effects of smoking; thus, issues regarding gen-
der differences are not entirely resolved. For example, it is
still not known whether susceptibility to lung cancer is
greater among women smokers than among men smok-
ers, or whether women are more likely than men to gain
weight following smoking cessation. Researchers are
strongly encouraged to use existing data sets to examine
results by gender and to do so in future studies. Where
these additional analyses suggest important gender differ-
ences, more research is needed to focus on the develop-
ment of interventions tailored to the special needs of girls
and women. As new “reduced-risk” tobacco products are
marketed in the future, it will also be important to learn
whether gender differences exist in the appeal and use of
such products, as well as the health consequences of their use.
• Better understand how to reduce current disparities
in smoking prevalence among women of different
groups, as defined by socioeconomic status, race,
ethnicity, and sexual orientation. Women with only 9
to 11 years of education are about three times as likely to
be smokers as are women with a college education. Ameri-
can Indian or Alaska Native women are much more likely
to smoke than are Hispanic women and Asian or Pacific
Islander women. Limited data also suggest that lesbian
women are more likely to smoke than are heterosexual
women. Among teenage girls, whites are much more likely
to smoke than are blacks. How can the decline in smok-
ing among women who are less well educated be acceler-
ated? Why are smoking rates so high among American
Indian women? What contributes to the relatively low
smoking prevalence among Hispanic women and Asian
or Pacific Islander women, and what can be done to pre-
vent smoking among them from rising in the future? What
positive influences contributed to the vast majority of black
teenage girls resisting smoking throughout the 1990s, in
stark contrast to the relatively high smoking prevalence
among white girls during the same period? The objective
is to reduce smoking to the lowest possible level across all
demographic groups. The answers to these questions will
provide crucial information for intervention efforts.
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• Determine why, during most of the 1990s, smoking
prevalence declined so little among women and
increased so markedly among teenage girls. This lack
of progress is a major concern and threatens to prolong
the epidemic of smoking-related disease among women.
What are the influences that have kept smoking preva-
lence relatively stagnant among women and have contrib-
uted to the sharp increases in prevalence among teenage
girls? Tobacco control policies are known to be effective
in reducing smoking, and smoking prevalence tends to
decline most where these policies are strongest. However,
efforts to curb tobacco use do not operate in a vacuum,
and powerful pro-tobacco influences (ranging from to-
bacco advertising to the use of tobacco in movies) have
promoted the social acceptability of smoking and thereby
have dampened the effects of tobacco control programs.
Moreover, ongoing monitoring of tobacco industry
attempts to target women in this country and abroad are
necessary for a comprehensive understanding of the
influences that encourage women to smoke and for
designing effective countermarketing campaigns. If, for
example, smoking in movies by female celebrities promotes
smoking, then discouraging such practices as well as
engaging well-known actresses to be spokespersons on the
issue of women and smoking should be a high priority.
• Develop a research and evaluation agenda related to
women and smoking. As noted above, the impact of
smoking and of exposure to environmental tobacco smoke
on the risk of some disease outcomes has been inadequately
studied for women. Determining whether gender-tailored
interventions increase the effectiveness of various smok-
ing prevention and cessation methods is important, as is
documenting whether any gender differences exist in the
effectiveness of pharmacologic treatments for tobacco ces-
sation. A need also exists to determine which tobacco pre-
vention and cessation interventions are most effective for
specific subgroups of girls and women, especially those at
highest risk for tobacco use (e.g., women with only 9 to
11 years of education, American Indian or Alaska Native
women, and women with depression). The sparse data
available on smoking among lesbian women suggest that
prevalence exceeds that of U.S. women overall, but better
data are clearly needed. Research designed to reduce dis-
parities in smoking prevalence across all subgroups of the
female population deserves high priority to help elimi-
nate future disparities in smoking-related diseases. The
components of programs and policies targeted to indi-
vidual women, and those targeted to communities that
produce the greatest reduction in smoking, need to be
identified. Progress on these and other issues will be
facilitated by the development of an agenda of research
and evaluation priorities related to women and smoking.
Act Now: We Know More than Enough
• Support efforts, at both individual and societal levels,
to reduce smoking and exposure to environmental
tobacco smoke among women. Proven smoking cessa-
tion methods are available for individual smokers, includ-
ing behavioral and pharmacologic approaches that benefit
women and men alike. Tobacco use treatments are among
the most cost-effective of preventive health interventions;
they should be part of all women’s health care programs,
and health insurance plans should cover such services.
Efforts to maximize smoking cessation and maintenance
of smoking cessation among women before, during, and
after pregnancy deserve high priority, because pregnancy
is a time of high motivation to quit and occurs when
women have many years of potential life left. With
respect to prevention, the knowledge that girls who are
more academically inclined or who are more physically
active are less likely to smoke suggests that supporting
positive outlets for mental and physical development will
contribute to reducing the tobacco epidemic as well.
Because regular cigarette smoking typically is initiated early
in the teenage years, effective smoking cessation and pre-
vention programs for adolescent girls and young women
are greatly needed. Societal-level efforts to reduce tobacco
use and exposure to environmental tobacco smoke include
media counter-advertising, increased tobacco taxes, laws
to reduce youth access to tobacco products, and bans on
smoking in public places.
• Enact comprehensive statewide tobacco control
programs—because they work. There are known strate-
gies for reducing the burden of smoking-related diseases,
but making the investment in these proven strategies
remains a challenge. Results from states such as Arizona,
California, Florida, Maine, Massachusetts, and Oregon
have demonstrated that smoking rates among both girls
and women can be dramatically reduced. California was
the first state to establish a comprehensive statewide
tobacco control program in 1990, and it is now starting
to observe the benefits of its sustained efforts: between
1988 and 1997, the incidence rate of lung cancer among
women declined by 4.8 percent in California but increased
by 13.2 percent in other regions of the United States (Cen-
ters for Disease Control and Prevention [CDC] 2000).
Another recent study concluded that the California pro-
gram was associated with 33,300 fewer deaths from heart
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disease between 1989 and 1997 among women and men
combined than would have been predicted if trends like
those observed in the rest of the country had continued
(Fichtenberg and Glantz 2000). Enormous monetary
settlement payments from state Medicaid lawsuits with
the tobacco industry have provided the resources to fund
major new comprehensive statewide tobacco control
efforts. However, a recent report found that only six states
were meeting the minimum funding recommendations
from CDC’s Best Practices for Comprehensive Tobacco
Control Programs (Campaign for Tobacco-Free Kids 2001).
Stop the Epidemic of Smoking and
Smoking-Related Diseases Among
Women Globally
• Do everything possible to thwart the emerging
epidemic of smoking among women in developing
countries. Multinational policies that discourage spread
of the epidemic of smoking and tobacco-related diseases
among women in countries where smoking prevalence has
traditionally been low should be strongly encouraged.
Efforts to disassociate cigarette smoking from progress in
achieving gender equity are particularly needed in the
developing world (Magardie 2000). Because smoking
prevalence among men is already high in many develop-
ing countries, even women who do not smoke themselves
are already at risk because they are exposed to environ-
mental tobacco smoke—and because they suffer the losses
of male loved ones who are dying of tobacco-related dis-
eases. It is urgent that what is already known about effec-
tive means of tobacco control at the societal level be
disseminated as soon as possible throughout the world. A
major measure of public health victory in the global war
against smoking would be the arrest of smoking preva-
lence at its still generally low level among women in
developing countries and a reversal of the now worrisome
signs of increases in smoking among them. In November
1999, the World Health Organization sponsored an
international conference on smoking among women and
youth, which took place in Kobe, Japan. The conference
resulted in the Kobe Declaration, which states that, “The
tobacco epidemic is an unrelenting public health disaster
that spares no society. There are already over 200 million
women smokers, and tobacco companies have launched
aggressive campaigns to recruit women and girls
worldwide....It is urgent that we find comprehensive
solutions to the danger of tobacco use and address the
epidemic among women and girls” (World Health Orga-
nization 1999b).
• All national governments should strongly support the
World Health Organization’s Framework Convention
for Tobacco Control (FCTC). The FCTC is an interna-
tional legal instrument designed to curb the global spread
of tobacco use through specific protocols, currently being
negotiated, that cover tobacco pricing, smuggling, adver-
tising and sponsorship, and other activities (World Health
Organization 1999a). In the words of Dr. Gro Harlem
Brundtland, director-general of the WHO, “If we do not
act decisively, a hundred years from now our grandchildren
and their children will look back and seriously question
how people claiming to be committed to public health
and social justice allowed the tobacco epidemic to unfold
unchecked” (Asma et al., in press).
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